What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Receptor
Bradley K. Taylor mainly investigates Hyperalgesia, Allodynia, Chemistry, Pharmacology and Neuroscience.
His Hyperalgesia study incorporates themes from Neuropathic pain and Endocrinology.
His Endocrinology research also works with subjects such as
- Receptor which is related to area like Nerve injury,
- Nociceptor which intersects with area such as Neuropeptide Y receptor and Spinal cord.
His research in Allodynia intersects with topics in Anesthesia, TRPV1 and Substance P.
Bradley K. Taylor has researched Pharmacology in several fields, including Spinal cord injury and Transplantation.
His work in the fields of Neuroscience, such as Inhibitory postsynaptic potential and Premovement neuronal activity, overlaps with other areas such as SNi and Locus coeruleus.
His most cited work include:
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. (194 citations)
- Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. (141 citations)
- Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling (114 citations)
What are the main themes of his work throughout his whole career to date?
Bradley K. Taylor mainly focuses on Hyperalgesia, Pharmacology, Neuropathic pain, Anesthesia and Neuroscience.
His work on Allodynia as part of general Hyperalgesia study is frequently linked to Chemistry, therefore connecting diverse disciplines of science.
His Pharmacology research is multidisciplinary, relying on both -Naloxone, Antagonist, Opioid, Experimental autoimmune encephalomyelitis and Sensitization.
His Neuropathic pain research is multidisciplinary, incorporating elements of Spinal cord injury, Microglia and Pioglitazone.
His Chronic pain study deals with Decoy intersecting with Intrathecal.
His work carried out in the field of Nociception brings together such families of science as Morphine, Stimulation and Neuropeptide Y receptor.
He most often published in these fields:
- Hyperalgesia (38.82%)
- Pharmacology (42.35%)
- Neuropathic pain (40.00%)
What were the highlights of his more recent work (between 2018-2021)?
- Neuropathic pain (40.00%)
- Pharmacology (42.35%)
- Sensitization (22.35%)
In recent papers he was focusing on the following fields of study:
Bradley K. Taylor mostly deals with Neuropathic pain, Pharmacology, Sensitization, Opioid and Neuropeptide Y receptor.
In his study, Neurodegeneration and Lesion is strongly linked to Spinal cord injury, which falls under the umbrella field of Neuropathic pain.
His biological study deals with issues like Antagonist, which deal with fields such as Channel blocker and Muscle tissue.
His Sensitization research incorporates elements of Anesthesia, Db/db Mouse, Type 2 diabetes and Cyclic adenosine monophosphate.
As part of one scientific family, Bradley K. Taylor deals mainly with the area of Opioid, narrowing it down to issues related to the Hyperalgesia, and often Naltrindole.
His Neuropeptide Y receptor study combines topics from a wide range of disciplines, such as Nociception, TRPV1, Nerve injury, Neuroscience and Peripheral nerve injury.
Between 2018 and 2021, his most popular works were:
- Facilitation of Neuropathic Pain by the NPY Y1 Receptor-Expressing Subpopulation of Excitatory Interneurons in the Dorsal Horn (21 citations)
- Facilitation of Neuropathic Pain by the NPY Y1 Receptor-Expressing Subpopulation of Excitatory Interneurons in the Dorsal Horn (21 citations)
- An NPY Y1 receptor antagonist unmasks latent sensitization and reveals the contribution of protein kinase A and Epac to chronic inflammatory pain (14 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Pharmacology
His primary scientific interests are in Neuropeptide Y receptor, Nerve injury, TRPV1, Neuropathic pain and Pharmacology.
His Neuropeptide Y receptor study combines topics in areas such as Internalization, Endocrinology, CNQX and Nociception.
The study incorporates disciplines such as Internal medicine, Stimulation and Peripheral nerve injury in addition to Nerve injury.
Bradley K. Taylor combines subjects such as Inhibitory postsynaptic potential, Excitatory postsynaptic potential and Chronic pain with his study of Neuropathic pain.
His research integrates issues of Channel blocker, Receptor antagonist, Transient receptor potential channel and Sensitization in his study of Pharmacology.
His Sensitization study integrates concerns from other disciplines, such as NMDA receptor, Adenylyl cyclase, Antagonist and Type 2 diabetes.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
